Nascent Completes Dosing Requirement in Final Cohort of Phase I Clinical Trial
NORTH PALM BEACH, FL / ACCESSWIRE / January 25, 2023 / Nascent Biotech, Inc. (OTCQB:NBIO) (“Nascent Biotech”, “Nascent”, or the “Company”), a clinical-stage [...]
Nascent Biotech News
AccessWire Feed
Nascent Biotech Press Releases
